Literature DB >> 8062216

Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines.

M Asamoto1, S M Cohen.   

Abstract

Prohibitin was isolated as a candidate antiproliferating gene in rat liver cells, and it has been suggested as a tumor suppressor gene in human breast cancer. We investigated the steady state level of prohibitin mRNA in rat bladder cell lines and in rat bladder carcinoma induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin, as well as the protein level in rat bladder epithelial cells. We also examined the prohibitin gene for mutations using the polymerase chain reaction (PCR) single strand conformation polymorphism (SSCP) and direct sequencing methods. All rat bladder tumors investigated and several cell lines had unexpectedly increased steady state levels of prohibitin mRNA compared with that of normal rat bladder or liver. The prohibitin protein was easily detected by Western blotting in all cell lines regardless of their malignant status or growth rate. However, PCR-SSCP and direct sequencing analysis showed no mutations in the prohibitin gene. These results These results indicate that prohibitin overexpression, but not mutations, may be involved in the early stage of rat bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062216     DOI: 10.1016/0304-3835(94)90320-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  A two-dimensional electrophoresis reference map of human ovary.

Authors:  Lei Wang; Ye-Fei Zhu; Xue-Jiang Guo; Ran Huo; Xiang Ma; Min Lin; Zuo-Min Zhou; Jia-Hao Sha
Journal:  J Mol Med (Berl)       Date:  2005-07-15       Impact factor: 4.599

2.  Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.

Authors:  N A Doudican; S J Orlow
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

3.  An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens.

Authors:  M M Montano; K Ekena; R Delage-Mourroux; W Chang; P Martini; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Small-molecule screening yields a compound that inhibits the cancer-associated transcription factor Hes1 via the PHB2 chaperone.

Authors:  Amelie Perron; Yoshihiro Nishikawa; Jun Iwata; Hiromi Shimojo; Junichiro Takaya; Kumiko Kobayashi; Itaru Imayoshi; Naasson M Mbenza; Mihoko Takenoya; Ryoichiro Kageyama; Yuzo Kodama; Motonari Uesugi
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

5.  A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance.

Authors:  Iryna Zubovych; Thomas Doundoulakis; Patrick G Harran; Michael G Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-10       Impact factor: 11.205

6.  Prohibitins are required for cancer cell proliferation and adhesion.

Authors:  Claudia Sievers; Gwendolyn Billig; Kathleen Gottschalk; Thomas Rudel
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

7.  Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.

Authors:  B Manivannan; P Rawson; T W Jordan; W E Secor; A C La Flamme
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

8.  Prohibitin: a potential biomarker for tissue-based detection of gastric cancer.

Authors:  Xiangdong Kang; Long Zhang; Jian Sun; Zhenhua Ni; Yanchun Ma; Xiaobo Chen; Xia Sheng; Teng Chen
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

9.  Increased expression of prohibitin and its relationship with poor prognosis in esophageal squamous cell carcinoma.

Authors:  Hong-Zheng Ren; Jin-Sheng Wang; Peng Wang; Guo-qing Pan; Ji-Fang Wen; Hua Fu; Xu-zheng Shan
Journal:  Pathol Oncol Res       Date:  2010-01-13       Impact factor: 3.201

10.  Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.

Authors:  Rosalind C Gregory-Bass; Moshood Olatinwo; Wei Xu; Roland Matthews; Jonathan K Stiles; Kelwyn Thomas; Dong Liu; Benjamin Tsang; Winston E Thompson
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.